In this video from the 2014 ASH Annual Meeting, Dr. Röllig discusses the results of the SORAML trial that tested sorafenib in patients with acute myeloid leukemia.
Christoph Röllig, MD
Advertisement
Articles by Christoph Röllig, MD
Advertisement
Latest Updated Articles
- Sorafenib Demonstrates Activity in AML
Published: December 9th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Mosunetuzumab Treatment Combo Yields Responses in High-Risk MCL
2
Giredestrant Combo Significantly Boosts PFS in ER+ Advanced Breast Cancer
3
Dara-KRd Regimen Displays Prolonged PFS in Newly Diagnosed Multiple Myeloma
4
How To Discuss Death? A Conversation of Mortality in Cancer Care
5
